Cargando…
Influence of gut microbiome on multiple myeloma: friend or foe?
Multiple myeloma (MM) is a malignancy of terminally differentiated plasma cells, which typically evolves over time from its precursor, monoclonal gammopathy of undetermined significance. While the underlying mechanisms of this evolution remain elusive, immunomodulatory factors affecting the bone mar...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312329/ https://www.ncbi.nlm.nih.gov/pubmed/32581045 http://dx.doi.org/10.1136/jitc-2020-000576 |
_version_ | 1783549703348027392 |
---|---|
author | Ahmed, Nausheen Ghannoum, Mahmoud Gallogly, Molly de Lima, Marcos Malek, Ehsan |
author_facet | Ahmed, Nausheen Ghannoum, Mahmoud Gallogly, Molly de Lima, Marcos Malek, Ehsan |
author_sort | Ahmed, Nausheen |
collection | PubMed |
description | Multiple myeloma (MM) is a malignancy of terminally differentiated plasma cells, which typically evolves over time from its precursor, monoclonal gammopathy of undetermined significance. While the underlying mechanisms of this evolution remain elusive, immunomodulatory factors affecting the bone marrow (BM) microenvironment are suspected to play a role. There is an increasing evidence that the gut microbiome exerts an influence on its host’s adaptive and innate immune systems, inflammatory pathways and the BM microenvironment. Dysbiosis, therefore, may impact tumorigenesis in MM. This article gives an overview of potential mechanisms by which the microbiome may influence the pathogenesis of MM, MM patients’ responses to treatment and toxicities experienced by MM patients undergoing autologous transplant. It also discusses the potential role of the mycobiome in MM, a less studied component of the microbiome. |
format | Online Article Text |
id | pubmed-7312329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-73123292020-06-26 Influence of gut microbiome on multiple myeloma: friend or foe? Ahmed, Nausheen Ghannoum, Mahmoud Gallogly, Molly de Lima, Marcos Malek, Ehsan J Immunother Cancer Commentary Multiple myeloma (MM) is a malignancy of terminally differentiated plasma cells, which typically evolves over time from its precursor, monoclonal gammopathy of undetermined significance. While the underlying mechanisms of this evolution remain elusive, immunomodulatory factors affecting the bone marrow (BM) microenvironment are suspected to play a role. There is an increasing evidence that the gut microbiome exerts an influence on its host’s adaptive and innate immune systems, inflammatory pathways and the BM microenvironment. Dysbiosis, therefore, may impact tumorigenesis in MM. This article gives an overview of potential mechanisms by which the microbiome may influence the pathogenesis of MM, MM patients’ responses to treatment and toxicities experienced by MM patients undergoing autologous transplant. It also discusses the potential role of the mycobiome in MM, a less studied component of the microbiome. BMJ Publishing Group 2020-06-23 /pmc/articles/PMC7312329/ /pubmed/32581045 http://dx.doi.org/10.1136/jitc-2020-000576 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Commentary Ahmed, Nausheen Ghannoum, Mahmoud Gallogly, Molly de Lima, Marcos Malek, Ehsan Influence of gut microbiome on multiple myeloma: friend or foe? |
title | Influence of gut microbiome on multiple myeloma: friend or foe? |
title_full | Influence of gut microbiome on multiple myeloma: friend or foe? |
title_fullStr | Influence of gut microbiome on multiple myeloma: friend or foe? |
title_full_unstemmed | Influence of gut microbiome on multiple myeloma: friend or foe? |
title_short | Influence of gut microbiome on multiple myeloma: friend or foe? |
title_sort | influence of gut microbiome on multiple myeloma: friend or foe? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312329/ https://www.ncbi.nlm.nih.gov/pubmed/32581045 http://dx.doi.org/10.1136/jitc-2020-000576 |
work_keys_str_mv | AT ahmednausheen influenceofgutmicrobiomeonmultiplemyelomafriendorfoe AT ghannoummahmoud influenceofgutmicrobiomeonmultiplemyelomafriendorfoe AT galloglymolly influenceofgutmicrobiomeonmultiplemyelomafriendorfoe AT delimamarcos influenceofgutmicrobiomeonmultiplemyelomafriendorfoe AT malekehsan influenceofgutmicrobiomeonmultiplemyelomafriendorfoe |